The headline
A next-generation feline leukemia virus vaccine received a positive regulatory opinion in Europe.
The science, explained
The product uses RNA-particle technology to present immune-system instructions differently from conventional vaccine platforms. A positive regulatory opinion is an important milestone, but availability, approved indications, and veterinary guidance can vary by country.
What it means for your cat
- This development concerns prevention of feline leukemia virus, not treatment of an existing cancer.
- Product availability and labeling may differ across regions.
- Ask your veterinarian to assess FeLV exposure risk and recommend an appropriate vaccination schedule.
The primary source
Read the underlying material from European Medicines Agency.
Editorial note: Cat Cancer News summarizes research for general information. It is not veterinary advice. Always discuss diagnosis and treatment with a licensed veterinarian.